Revenue of the cold and cough remedies industry Indonesia 2020-2029

The revenue in the 'Cold & Cough Remedies' segment of the OTC pharmaceuticals market in Indonesia was forecast to continuously increase between 2024 and 2029 by in total 349.6 million U.S. dollars (+53.11 percent). After the ninth consecutive increasing year, the indicator is estimated to reach 1 billion U.S. dollars and therefore a new peak in 2029. Notably, the revenue of the 'Cold & Cough Remedies' segment of the OTC pharmaceuticals market was continuously increasing over the past years. The Statista Market Insights cover a broad range of additional markets.

印尼非处方药物市场‘感冒及咳嗽药物’细分领域的收入预计将在2024年至2029年期间持续增长，总计增长3.496亿美元（增长53.11%）。在连续九年增长之后，预计该指标将达到10亿美元，从而在2029年创下新的历史高点。值得注意的是，‘感冒及咳嗽药物’细分领域的收入在过去几年中持续上升。Statista市场洞察涵盖了广泛的其它市场。